Neoadjuvant chemotherapy with paclitaxel/carboplatin/bevacizumab in advanced vulvar cancer: Time to rethink standard of care?

Vulvar cancer remains a rare entity and treatment options for advanced disease are limited. This case report highlights the excellent response of two patients with FIGO Stage IV vulvar cancer treated with neoadjuvant paclitaxel/carboplatin/bevacizumab chemotherapy. While definitive conclusions are i...

Descripción completa

Detalles Bibliográficos
Autores principales: Klavans, Madison R., Erickson, Sarah H., Modesitt, Susan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498849/
https://www.ncbi.nlm.nih.gov/pubmed/32984493
http://dx.doi.org/10.1016/j.gore.2020.100631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498849/
https://www.ncbi.nlm.nih.gov/pubmed/32984493
http://dx.doi.org/10.1016/j.gore.2020.100631

Ejemplares similares